269
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Orbifloxacin: A Review of Properties, Its Antibacterial Activities, Pharmacokinetic/Pharmacodynamic Characteristics, Therapeutic Use, and Analytical Methods

&
Pages 79-99 | Published online: 22 Feb 2013

REFERENCES

  • Abd El-Aty , A. M. , Choi , J.-H. , Ko , M.-W. , Khay , S. , Goudah , A. , Shin , H.-C. , Kim , J.-S. , Chang , B.-J. , Lee , C.-H. and Shim , J.-H. 2009 . Approaches for Application of Sub and Supercritical Fluid Extraction for Quantification of Orbifloxacin from Plasma and Milk: Application to Disposition Kinetics . Anal. Chim. Acta , 631 : 108 – 115 .
  • Abo-El-Sooud , K. and Goudah , A. 2009 . nfluence of Pasteurella multocida Infection on the Pharmacokinetic Behavior of Marbofloxacin after Intravenous and Intramuscular Administrations in Rabbits . J. Vet. Pharmacol. Ther , 33 : 63 – 68 .
  • Albarellos , G. A. and Landoni , M. F. 2009 . Current Concepts on the Use of Antimicrobials in Cats . Vet. J. , 180 : 304 – 316 .
  • Amidon , G. L. , Lennernas , H. , Shah , V. P. and Crison , J. R. A . 1995 . Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of an In Vitro Drug Product Dissolution and In Vivo Bioavailability . Pharm. Res , 12 : 413 – 420 .
  • Authier , S. , Paquette , D. , Labrecque , O. and Messier , S. 2006 . Comparison of Susceptibility to Antimicrobials of Bacterial Isolates from Companion Animals in a Veterinary Diagnostic Laboratory in Canada between 2 Time Points 10 Years Apart . Can. Vet. J , 47 : 774 – 778 .
  • Ball , P. 2000 . Quinolone Generations: Natural History or Natural Selection . J. Antimicrob. Chemother. , 46 : 17 – 24 .
  • Boothe , D. M. , Boeckh , A. , Simpson , R. B. and Dubose , K. 2006 . Comparison of Pharmacodynamic and Pharmacokinetic Indices of Efficacy for 5 Fluoroquinolones toward Pathogens of Dogs and Cats . J. Vet. Intern. Med. , 20 : 1297 – 1306 .
  • 2011 . British Pharmacopoeia , Vol. 1 , 88 – 90 . London : Her Majesty's Stationery Office .
  • Cazedey , E. C. L. and Salgado , H. R. N. 2011 . Development and Validation of a Microbiological Agar Assay for Determination of Orbifloxacin in Pharmaceutical Preparations . Pharmaceutics , 3 : 572 – 581 .
  • Cazedey , E. C. L. , Othman , A. , Garg , S. and Salgado , H. R. N. 2011 . A Validated Stability-Indicating LC Method for Orbifloxacin in the Presence of Degradation Products . Curr. Pharm. Anal , 7 ( 3 ) : 176 – 181 .
  • Cho , S. , Fossler , C. P. , Diez-Gonzalez , F. , Wells , S. J. , Hedberg , C. W. , Kaneene , J. B. , Ruegg , P. L. , Warnick , L. D. and Bender , J. B. 2007 . Antimicrobial Susceptibility of Shiga Toxin-Producing Escherichia coli Isolated from Organic Dairy Farms, Conventional Dairy Farms, and County Fairs in Minnesota . Foodborne Pathog. Dis. , 4 ( 2 ) : 178 – 186 .
  • Cho , H. J. , Yi , H. , Cho , S. M. , Lee , D. G. , Cho , K. , Abd-El-Aty , A. M. , Shim , J. H. , Lee , S. H. , Jeong , J. Y. and Shin , H. C. 2010 . Single-Step Extraction Followed by LC for Determination of (Fluoro)Quinolone Drug Residues in Muscle, Eggs, and Milk . J. Sep. Sci. , 33 ( 8 ) : 1034 – 1043 .
  • Chonan , T. , Fujimoto , T. , Inoue , M. , Tazawa , T. and Ogawa , H. 2008 . Multiresidue Determination of Quinolones in Animal and Fishery Products by HPLC [in Japanese] . Shokuhin Eiseiqaku Zasshi , 49 ( 3 ) : 244 – 248 .
  • Clinical and Laboratory Standards Institute (CLSI) . 2002 . Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 2nd ed. , Wayne , Penn : Clinical and Laboratory Standards Institute . CLSI document M31-A2
  • Clinical and Laboratory Standards Institute (CLSI) . 2004 . Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard – Information Supplement , Wayne , Penn : Clinical and Laboratory Standards Institute . CLSI document M31-S1
  • Clinical and Laboratory Standards Institute (CLSI) . 2008 . Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 3rd ed. , Wayne , Penn : Clinical and Laboratory Standards Institute . CLSI document M31-A3
  • Clinical and Laboratory Standards Institute (CLSI) . 2009 . Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 8th ed. , Wayne , Penn : Clinical and Laboratory Standards Institute . CLSI document M07-A8
  • Coelho-Baptista , B. , Costa , M. , Duarte Correia , J. and Pomba , C. 2003 . In vitro Activity of Enrofloxacin, Marbofloxacin, Orbifloxacin and Ciprofloxacin against Clinical Strains of Staphylococcus intermedius Isolated from Dogs in Portugal . J. Vet. Pharmacol. Ther , 26 ( Suppl. 1 ) : 155 – 156 .
  • Cox , S. K. 2007 . Allometric Scaling of Marbofloxacin, Moxifloxacin, Danofloxacin and Difloxacin Pharmacokinetics: A Retrospective Analysis . J. Vet. Pharmacol. Ther. , 30 : 381 – 386 .
  • Davis , J. L. , Papich , M. G. and Weingarten , A. 2006 . The Pharmacokinetics of Orbifloxacin in the Horse Following Oral and Intravenous Administration . J. Vet. Pharmacol. Ther. , 29 : 191 – 197 .
  • Duan , J. and Yuan , Z. 2001 . Development of an Indirect Competitive ELISA for Ciprofloxacin Residues in Food Animal Edible Tissues . J. Agric. Food Chem. , 49 : 1087 – 1089 .
  • Elias , G. , Lee , J.-S. , Hwang , M.-H. , Park , Y.-S. , Cho , K.-H. , Kim , Y.-H. and Park , S.-C. 2009 . Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Integration of Orbifloxacin in Korean Hanwoo Cattle . J. Vet. Pharmacol. Ther. , 32 : 219 – 228 .
  • Engberg , J. , Aarestrup , F. M. , Taylor , D. E. , Gerner-Smidt , P. and Nachamkin , I. 2001 . Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates . Emerg. Infect. Dis , 7 : 24 – 34 .
  • Esaki , H. , Asai , T. , Kojima , A. , Ishihara , K. , Morioka , A. , Tamura , Y. and Takahashi , T. 2005 . Antimicrobial Susceptibility of Mannheimia haemolytica Isolates from Cattle on Japan from 2001 to 2002 . J. Vet. Med. Sci , 67 ( 1 ) : 75 – 77 .
  • Fujii , T. , Takatsu , S. , Stegemann , M. , Ogata , M. and Kamata , S. 2007 . Clinical Efficacy and Safety of an Injectable Formulation of Cefovecin in the Treatment of Bacterial Skin Infections of Dogs . Jpn. J. Vet. Dermatol , 13 ( 2 ) : 81 – 88 .
  • Fujita , M. , Tamura , W. , Tozawa , T. and Kometani , T. 2008 . Application of Simultaneous Determination Method of Residual Veterinary Drugs to Processed Foods [in Japanese] . Shokuhin Eiseiqaku Zasshi , 49 ( 6 ) : 416 – 421 .
  • Ganière , J. P. , Médaille , C. and Etoré , F. 2004 . In Vitro Antimicrobial Activity of Orbifloxacin against Staphylococcus intermedius Isolates from Canine Skin and Ear Infections . Res. Vet. Sci , 77 : 67 – 71 .
  • García , M. A. , Solans , C. , Aramayona , J. J. , Rueda , S. and Bregante , M. A. 1999 . Determination of Orbifloxacin in Rabbit Plasma by High-Performance Liquid Chromatography with Fluorescence Detection . J. Chromatogr. Sci. , 37 ( 6 ) : 199 – 202 .
  • Gebru , E. , Lee , J.-S. , Chang , Z.-Q. , Hwang , M.-H. , Cheng , H. and Park , S.-C. 2009 . Integration of Pharmacokinetic and Pharmacodynamic Indices of Orbifloxacin in Beagle Dogs after a Single Intravenous and Intramuscular Administration . Antimicrob. Agents Chemother. , 53 ( 7 ) : 3024 – 3029 .
  • Gottlieb , S. , Wigney , D. I. , Martin , P. A. , Norris , J. M. , Malik , R. and Govendir , M. 2008 . Susceptibility of Canine and Feline Escherichia coli and Canine Staphylococcus intermedius Isolates to Fluoroquinolones . Aust. Vet. J , 86 ( 4 ) : 147 – 152 .
  • Goudah , A. and Abo-El-Sooud , K. 2008 . Pharmacokinetics and Milk Penetration of Orbifloxacin after Intravenous and Intramuscular Injections to Dromedary Lactating Camels (Camelus Dromedaries) . J. Vet. Pharmacol. Ther. , 31 : 276 – 280 .
  • Goudah , A. , Cho , H. J. , Shin , H. C. , Shim , J. H. , Regmi , N. L. , Shimoda , M. and Abd-El-Aty , A. M. 2009 . Pharmacokinetics and Milk Distribution Characteristics of Orbifloxacin Following Intravenous and Intramuscular Injection in Lactating Ewes . J. Vet. Pharmacol. Ther. , 32 ( 4 ) : 338 – 344 .
  • Haines , G. R. , Brown , M. P. , Gronwall , R. R. , Merritt , K. A. and Baltzley , L. K. 2001 . Pharmacokinetics of Orbifloxacin and Its Concentration in Body Fluids and in Endometrial Tissues of Mares . Can. J. Vet. Res. , 65 : 181 – 187 .
  • Hariharan , H. , Coles , M. , Poole , D. , Lund , L. and Page , R. 2006 . Update on Antimicrobial Susceptibilities of Bacterial Isolates from Canine and Feline Otitis Externa . Can. Vet. J , 47 ( 3 ) : 253 – 255 .
  • Heinen , E. Comparative Pharmacokinetics of Enrofloxacin, Marbofloxacin, and Orbifloxacin in Cats after Single Oral Administration [Abstract L11] . Proceedings of the Eighth International Congress of the European Association for Veterinary Pharmacology and Toxicology, Israel , Oxford , , UK : Blackwell Science, Ltd. .
  • Heinen , E. 2002 . Comparative Serum Pharmacokinetics of the Fluoroquinolones Enrofloxacin, Difloxacin, Marbofloxacin, and Orbifloxacin in Dogs after Single Oral Administration . J. Vet. Pharmacol. Ther. , 25 : 1 – 5 .
  • Hung , S.-W. , Shih , C.-W. , Chen , B.-R. , Tu , C.-Y. , Ling , Y.-F. , Tsou , L. T. , Ho , S. P. and Wang , W. S. A . 2007 . New Detection Technique for Fluoroquinolone-Conjugated Proteins by High Performance Liquid Chromatography with UV/Fluorescence Detectors . J. Food Drug Anal. , 15 ( 1 ) : 71 – 74 .
  • Ibrahem , M. D. , Atta , A. H. and Shalaby , M. A. 2010 . Bioavailability of Orbifloxacin in African Sharptooth Catfish, Clarias gariepinus, and Its Efficacy in Control of Induced Edwardsiellosis . J. Am. Sci. , 6 ( 6 ) : 236 – 244 .
  • Ihrke , P. J. 1984 . Therapeutic Strategies Involving Antimicrobial Treatment of the Skin in Small Animals . J. Am. Vet. Med. Assoc , 185 : 1165 – 1168 .
  • Ihrke , P. J. , Papich , M. G. and Demanuelle , T. C. 1999 . The Use of Fluoroquinolones in Veterinary Dermatology . Vet. Dermatol. , 10 : 193 – 204 .
  • Johnston , L. , Mackay , L. and Croft , M. 2002 . Determination of Quinolones and Fluoroquinolones in Fish Tissue and Seafood by High-Performance Liquid Chromatography with Electrospray Ionisation Tandem Mass Spectrometric Detection . J. Chromatogr. A , 982 : 97 – 109 .
  • Kajita , H. and Hatakeyama , E. 2008 . Simultaneous Determination of Residual Veterinary Drugs in Livestock Products and Fish by Liquid Chromatography with Tandem Mass Spectrometry [in Japanese] . Shokuhin Eiseiqaku Zasshi , 49 ( 6 ) : 381 – 389 .
  • Kay-Mugford , P. A. , Weingarten , A. J. , Ngoh , M. , Zolynas , R. , White , A. , Katz , T. , Simmons , R. and Varma , K. J. 2002 . Determination of Plasma and Skin Concentrations of Orbifloxacin in Dogs with Clinically Normal Skin and Dogs with Pyoderma . Vet. Ther. , 3 ( 4 ) : 402 – 408 .
  • Kumazawa , J. and Yagisawa , M. 2002 . The History of Antibiotics: The Japanese Story . J. Infect. Chemother. , 8 : 125 – 133 .
  • Li , Y. L. , Hao , X. L. , Ji , B. Q. , Xu , C. L. , Chen , W. , Shen , C. Y. and Ding , T. 2009 . Rapid Determination of 19 Quinolone Residues in Spiked Fish and Pig Muscle by High-Performance Liquid Chromatography (HPLC) Tandem Mass Spectrometry . Food Addit. Contam. , 26 ( 3 ) : 306 – 313 .
  • Linder , J. S. , Huang , E. S. , Steinman , M. A. , Gonzales , R. and Stafford , R. S. 2005 . Fluoroquinolone Prescribing in the United States: 1995 to 2002 . Am. J. Med. , 118 ( 3 ) : 259 – 268 .
  • Llinàs , A. , Glen , R. C. and Goodman , J. M. 2008 . Solubility Challenge: Can You Predict Solubilities of 32 Molecules Using a Database of 100 Reliable Measurements? . J. Chem. Inf. Model , 48 : 1289 – 1303 .
  • Llorent-Martínez , E. J. , Ortega-Barrales , P. , Molina-Díaz , A. and Ruiz-Medina , A. 2008 . Implementation of Terbium-Sensitized Luminescence in Sequential-Injection Analysis for Automatic Analysis of Orbifloxacin . Anal. Bioanal. Chem. , 392 : 1397 – 1403 .
  • Marín , P. , Escudero , E. , Fernández-Varón , E. and Cárceles , C. M. 2007 . Pharmacokinetics and Milk Penetration of Orbifloxacin after Intravenous, Subcutaneous, and Intramuscular Administration to Lactating Goats . J. Dairy Sci. , 90 : 4219 – 4225 .
  • Marín , P. , Fernández-Varón , E. , Escudero , E. , Vancraeynest , D. and Cárceles , C. M. 2008 . Pharmacokinetic–Pharmacodynamic Integration of Orbifloxacin in Rabbits after Intravenous, Subcutaneous and Intramuscular Administration . J. Vet. Pharmacol. Ther. , 31 : 77 – 82 .
  • Martinez , M. , Augsburger , L. , Johnston , T. and Jones , W. W. 2002 . Applying the Biopharmaceutics Classification System to Veterinary Pharmaceutical Products. Part I. Biopharmaceutics and Formulation Considerations . Adv. Drug Deliv. Rev. , 54 : 805 – 824 .
  • Martinez , M. , McDermott , P. and Walker , R. 2006 . Pharmacology of the Fluoroquinolones: A Perspective for the Use in Domestic Animals . Vet. J. , 172 : 10 – 28 .
  • Martínez-Martínez , L. , Pascual , A. and Jacoby , G. A. 1998 . Quinolone Resistance from a Transferable Plasmid . Lancet , 351 ( 9105 ) : 797 – 799 .
  • Matsumoto , S. , Takahashi , M. , Yoshida , M. , Komatsu , T. , Kitadai , N. , Horii , Y. and Katae , H. 1997 . Absorption, Distribution and Excretion of Orbifloxacin in Dogs and Cats [in Japanese] . J. Jpn. Vet. Med. Assoc. , 50 : 470 – 474 .
  • Matsumoto , S. , Nakai , M. , Yoshida , M. and Katae , H. A . 1999a . Study of Metabolites Isolated from Urine Samples of Pigs and Calves Administered Orbifloxacin . J. Vet. Pharmacol. Ther. , 22 : 286 – 289 .
  • Matsumoto , S. , Kitadai , N. , Nakata , K. and Katae , H. 1999b . Combined In Vitro Effects of Orbifloxacin and Fosfomycin on S. dublin and S. typhimurium Isolated from Calves [in Japanese] . J. Jpn. Vet. Med. Assoc , 53 : 1 – 6 .
  • Matsumoto , S. , Takahashi , M. , Kitadai , N. and Katae , H. A. 1998a . Study of Metabolites Isolated from the Urine Samples of Cats and Dogs Administered Orbifloxacin . J. Vet. Med. Sci. , 60 ( 11 ) : 1259 – 1261 .
  • Matsumoto , S. , Nakai , M. , Yoshida , M. and Katae , H. 1998b . Absorption, Distribution and Excretion of Orbifloxacin in Swine and Calves [in Japanese] . J. Jpn. Vet. Med. Assoc. , 51 : 13 – 18 .
  • McKay , L. , Rose , C. D. , Matousek , J. L. , Schmeitzel , L. S. , Gibson , N. M. and Gaskin , J. M. 2007 . Antimicrobial Testing of Selected Fluoroquinolones against Pseudomonas aeruginosa Isolated from Canine Otitis . J. Am. Anim. Hosp. Assoc , 43 : 307 – 312 .
  • Morimura , T. , Ohno , T. , Matsukura , H. and Nobuhara , Y. 1995a . Photodegradation Kinetics of the New Antibacterial Fluoroquinolone Derivative, Orbifloxacin, in Aqueous Solution . Chem. Pharm. Bull. , 43 ( 6 ) : 1000 – 1004 .
  • Morimura , T. , Ohno , T. , Matsukura , H. and Nobuhara , Y. 1995b . Degradation Kinetics of the New Antibacterial Fluoroquinolone Derivative, Orbifloxacin, in Aqueous Solution . Chem. Pharm. Bull. , 43 ( 6 ) : 1052 – 1054 .
  • Morimura , T. , Kohno , K. , Nobuhara , Y. and Matsukura , H. 1997a . Photoreaction and Active Oxygen Generation by Photosensitization of a New Antibacterial Fluoroquinolone Derivative, Orbifloxacin, in the Presence of Chloride Ion . Chem. Pharm. Bull. , 45 ( 11 ) : 1828 – 1832 .
  • Morimura , T. , Nobuhara , Y. and Matsukura , H. 1997b . Photodegradation Products of a New Antibacterial Fluoroquinolone Derivative, Orbifloxacin, in Aqueous Solution . Chem. Pharm. Bull. , 45 ( 2 ) : 373 – 377 .
  • Morioka , A. , Asai , T. , Ishihara , K. , Kojima , A. , Tamura , Y. and Takahashi , T. 2005 . In vitro Activity of 24 Antimicrobial Agents against Staphylococcus and Streptococcus Isolated from Diseased Animals in Japan . J. Vet. Med. Sci. , 67 ( 2 ) : 207 – 210 .
  • Nakamura , S. 1995 . Veterinary Use of New Quinolones in Japan . Drugs , 49 ( Suppl. 2 ) : 152 – 158 .
  • O’Neil , M. J. 2006 . The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals, 14th ed. , 1182 Whitehouse Station , N.J. : Merck & Co. .
  • Papich , M. G. and Riviere , J. E. 2001 . “ Fluoroquinolone Antimicrobial Drugs ” . In Veterinary Pharmacology and Therapeutics, 8th ed. , Edited by: Adams , H. R. 898 – 917 . Ames : Iowa State University Press .
  • Pirro , F. , Edingloh , M. and Schmeer , N. 1999 . Bactericidal and Inhibitory Activity of Enrofloxacin and Other Fluoroquinolones in Small Animal Pathogens . Compendium on Continuing Education for the Practicing Veterinarian , 21 ( Suppl. 12M ) : 19 – 25 .
  • Regmi , N. L. , Abd El-Aty , A. M. , Kubota , R. , Shah , S. S. and Shimoda , M. 2007 . Lack of Inhibitory Effects of Several Fluoroquinolones on Cytochrome P-450 3A Activities at Clinical Dosage in Dogs . J. Vet. Pharmacol. Ther. , 30 : 37 – 42 .
  • Riddle , C. , Lemons , C. L. , Papich , M. G. and Altier , C. 2000 . Evaluation of Ciprofloxacin as a Representative of Veterinary Fluoroquinolones in Susceptibility Testing . J. Clin. Microbiol. , 38 : 1636 – 1637 .
  • Rosser , E. J. 2004 . Causes of Otitis Externa . Vet. Clin. North Am. Small Anim. Pract. , 34 : 459 – 468 .
  • Rubin , J. , Walker , R. D. , Blickenstaff , K. , Bodeis-Jones , S. and Zhao , S. 2008 . Antimicrobial Resistance and Genetic Characterization of Fluoroquinolone Resistance of Pseudomonas aeruginosa Isolated from Canine Infections . Vet. Microbiol. , 131 : 164 – 172 .
  • Saito , M. , Kozutsumi , D. , Kawasaki , M. , Kanbashi , M. , Nakamura , R. , Sato , Y. and Endo , M. 2008 . Multiresidue Method for Pesticides and Veterinary Drugs in Bovine Milk Using GC/MS and LC/MS/MS [in Japanese] . Shokuhin Eiseiqaku Zasshi , 49 ( 3 ) : 228 – 238 .
  • Santoke , H. , Song , W. , Cooper , W. J. , Greaves , J. and Miller , G. E. 2009 . Free-Radical-Induced Oxidative and Reductive Degradation of Fluoroquinolone Pharmaceuticals: Kinetic Studies and Degradation Mechanism . J. Phys. Chem. A , 113 : 7846 – 7851 .
  • Sárközy , G. 2001 . Quinolones: A Class of Antimicrobial Agents . Vet. Med , 46 ( 9-10 ) : 257 – 274 .
  • Schneider , M. J. and Donoghue , D. J. 2002 . Multiresidue Analysis of Fluoroquinolone Antibiotics in Chicken Tissue Using Liquid Chromatography-Fluorescence-Multiple Mass Spectrometry . J. Chromatogr. B , 780 : 83 – 92 .
  • Schneider , M. J. and Donoghue , D. J. 2003 . Multiresidue Determination of Fluoroquinolone Antibiotics in Eggs Using Liquid Chromatography–Fluorescence–Mass Spectrometry . Anal. Chim. Acta , 483 : 39 – 49 .
  • Schneider , M. J. , Vazquez-Moreno , L. , Bermudez-Almada , M. C. , Guardado , R. B. and Ortega-Nieblas , M. 2005 . Multiresidue Determination of Fluoroquinolones in Shrimp by Liquid Chromatography-Fluorescence-Mass Spectrometry . J. AOAC Int. , 88 ( 4 ) : 1160 – 1166 .
  • Schneider , M. J. , Reyes-Herrera , I. and Donoghue , D. J. 2007 . Evaluation of Serum as a Potential Matrix for Multiresidue Determination of Fluoroquinolone Antibiotics in Chicken Using Liquid Chromatography-Fluorescence-Mass Spectrometry . J. AOAC Int. , 90 ( 6 ) : 1716 – 1723 .
  • Scott , D. , Miller , W. H. and Miller , C. E. 2001 . “ Bacterial Skin Diseases ” . In Muller and Kirk's Small Animal Dermatology, 6th ed. , Edited by: Muller , W. 274 – 335 . Philadelphia : Saunders .
  • Scott , D. W. , Peters , J. and Miller , W. H. Jr. 2006 . Efficacy of Orbifloxacin Tablets for the Treatment of Superficial and Deep Pyoderma Due to Staphylococcus intermedius Infection in Dogs . Can. Vet. J , 47 : 999 – 1002 .
  • Shimoda , M. , Abd El-Aty , A. M. , Nakamura , M. and Kokue , E. 2003 . Inhibitory Effects of Some Fluoroquinolones on Cytochrome P450 1A Activities of Canine Hepatic Microsomes . J. Vet. Pharmacol. Ther. , 26 ( Suppl. 1 ) : 111 – 112 .
  • Shryock , T. R. 2001 . NCCLS Quality Control Values for Veterinary-Use Fluoroquinolones [letter] . J. Clin. Microbiol , 39 ( 4 ) : 1680 – 1681 .
  • Tabasi , S. H. , Fahmy , R. , Bensley , D. , O’Brien , C. and Hoag , S. W. 2008a . Quality by Design, Part I: Application of NIR Spectroscopy to Monitor Tablet Manufacturing Process . J. Pharm. Sci. , 97 ( 9 ) : 4040 – 4051 .
  • Tabasi , S. H. , Fahmy , R. , Bensley , D. , O’Brien , C. and Hoag , S. W. 2008b . Quality by Design, Part II: Application of NIR Spectroscopy to Monitor the Coating Process for a Pharmaceutical Sustained Release Product . J. Pharm. Sci. , 97 ( 9 ) : 4052 – 4066 .
  • Tabasi , S. H. , Fahmy , R. , Bensley , D. , O’Brien , C. and Hoag , S. W. 2008c . Quality by Design, Part III: Study of Curing Process of Sustained Release Coated Products Using NIR Spectroscopy . J. Pharm. Sci. , 97 ( 9 ) : 4067 – 4086 .
  • U.S. Food and Drug Administration . April 22, 1997 . Freedom of Information Summary: Orbax. NADA 141-081. 62(103) , Rockville , MD : FDA . http://www.gpo.gov/fdsys/pkg/FR-1997-05-29/html/97-14107.htm (accessed 1/24/11).
  • U.S. Food and Drug Administration . Aug 22, 2010 . Oral Dosage Form New Animal Drugs; Orbifloxacin Suspension. NADA 141-305. 75(91) , Rockville , MD : FDA . http://www.gpo.gov/fdsys/pkg/FR-2010-05-12/html/2010-11245.htm (accessed 1/24/11)
  • U.S. Food and Drug Administration . NADA 141–081 Orbax™ - original approval [media release] 2011 Jan 30 . http://www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm117014.htm (accessed 5/02/12). Latest update: April 26, 2012
  • 2011 . U.S. Pharmacopeia, 34th ed , 3732 – 3734 . Rockville , Md : United States Pharmacopeial Convention .
  • Walker , R. D. 2000 . The Use of Fluoroquinolones for Companion Animal Therapy . Aust. Vet. J. , 2 : 8490
  • Yamada , R. , Kozono , M. , Ohmori , T. , Morimatsu , F. and Kitayama , M. 2006 . Simultaneous Determination of Residual Veterinary Drugs in Bovine, Porcine, and Chicken Muscle Using Liquid Chromatography Coupled with Electrospray Ionization Tandem Mass Spectrometry . Biosci. Biotechnol. Biochem. , 70 ( 1 ) : 54 – 65 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.